EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non‐ RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome

Gabriela Jeesoo Kim iD, Alexsandra Christianne Malaquias iD, Debora Romeo Bertola iD, Raissa Carneiro Rezende iD, Laurana De Polli Cellin, Lucas Vieira Lacerda Pires, Ana Maria Santillan-Vasconez, Antônio Marcondes Lerario iD, Renata da Cunha Scalco iD, Alexander Augusto de Lima Jorge iD

American Journal of Medical Genetics Part A · 2026-03 · 200 (3) · 661-672

DOI: 10.1002/ajmg.a.64291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 25.10.2025. Verfasst von Gabriela Jeesoo Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Genetic Endocrinology (LIM25), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Noonan Syndrome, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noonan Syndrome (NS) is a clinically and genetically heterogeneous condition characterized by typical facial dysmorphisms, short stature, congenital heart defects, and developmental delays. While variants in genes such as PTPN11 , SOS1 , and RAF1 account for most genetically confirmed cases, diagnosis is challenging due to phenotypic overlap with other syndromes. In this retrospective study, we reviewed 192 patients with a clinical diagnosis of NS at a single tertiary center. Genetic diagnosis of NS was confirmed in 133 patients (69.4%) and diagnosis of non‐NS RASopathies was confirmed in 5 patients via targeted RASopathy panels. Exome sequencing (ES) was performed in 20 of the undiagnosed patients. In six cases, alternative genetic diagnoses were established due to variants in SETD5 , BRPF1 , DPH1 , ACTB , CREBBP , and GATA4 , genes associated with syndromes presenting overlapping phenotypes with NS. Our findings emphasize the utility of a hypothesis‐free approach that uses phenotypic features to prioritize variants in resolving diagnostic uncertainty in NS‐like presentations. These findings also highlight the need to broaden differential diagnoses beyond RASopathies when genetic confirmation of NS cannot be established.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noonan SyndromeGenetic Predisposition to DiseaseHumansMaleFemaleChild, PreschoolChildExome SequencingInfantPhenotypeAdolescentRetrospective StudiesMutationHeart Defects, CongenitalGenetic Association StudiesAdultDiagnosis, Differentialras ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11

Stichwörter der Autor:innen

Noonan syndromeexome sequencingsyndromic short stature

Substanzen

PTPN11 protein, humanras ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11

Autor:innen und Institutionen

  • Unit of Genetic Endocrinology (LIM25), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Unidade de Endocrinologia Pediatrica, Departamento de Pediatria, Irmandade da Santa Casa de Misericordia de Sao Paulo, Sao Paulo, Brazil.
  • Unidade de Genetica, Instituto da Crianca/Faculdade de Medicina da Universidade de Sao Paulo (FMUSP)/Hospital das Clinicas da Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Gabriela Jeesoo Kim, Alexsandra Christianne Malaquias, Debora Romeo Bertola, Raissa Carneiro Rezende, Antônio Marcondes Lerario, Renata da Cunha Scalco, Alexander Augusto de Lima Jorge

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Kim, G. J., Malaquias, A. C., Bertola, D. R., Rezende, R. C., Cellin, L. P., Pires, L. V. L., Santillan-Vasconez, A. M., Lerario, A. M., Scalco, R. D. C., & Jorge, A. A. L. (2026). Non‐ RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome. American Journal of Medical Genetics Part A, 200(3), 661-672. https://doi.org/10.1002/ajmg.a.64291

Vancouver

Kim GJ, Malaquias AC, Bertola DR, Rezende RC, Cellin LP, Pires LVL, et al. Non‐ RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome. American Journal of Medical Genetics Part A. 2026;200(3):661-672. doi:10.1002/ajmg.a.64291

BibTeX
@article{Kim2026,
  author = {Kim, Gabriela Jeesoo and Malaquias, Alexsandra Christianne and Bertola, Debora Romeo and Rezende, Raissa Carneiro and Cellin, Laurana De Polli and Pires, Lucas Vieira Lacerda and Santillan-Vasconez, Ana Maria and Lerario, Antônio Marcondes and Scalco, Renata da Cunha and Jorge, Alexander Augusto de Lima},
  title = {Non‐ RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  volume = {200},
  number = {3},
  pages = {661--672},
  doi = {10.1002/ajmg.a.64291}
}
Kostenlos starten →